ACST logo

ACST Acasti Pharma Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$3.37
+0.13 (+4.01%)

Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Lav…

Market Cap: $34.17Mwww.gracetx.com

Price

No data yet.

Social Signal Score

30
5d
—
30d
30
2 mentions
—
60d
30
2 mentions
—
90d
30
2 mentions
—
news: 2

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 2Sell 0Strong Sell 0

Revenue

$0.00-100.00%
$-32.0K$1.59M$3.21M$4.83M
May 2016Jun 2026

Analyst Estimates

FY2026
$-0.98
$-0.98–$-0.98
1 analysts
FY2027
$-0.68
$-0.85–$-0.51
2 analysts
FY2028
$0.23
$0.23–$0.23
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Prashant Kohli
Sector
Healthcare
Industry
Biotechnology
Employees
32
Beta
1.52
Country
CA
Piotroski score
2 / 9 (Weak)
Altman Z-score
8.80
www.gracetx.com